283 related articles for article (PubMed ID: 24204926)
21. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
22. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.
Long JZ; Nomura DK; Cravatt BF
Chem Biol; 2009 Jul; 16(7):744-53. PubMed ID: 19635411
[TBL] [Abstract][Full Text] [Related]
23. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
25. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
[TBL] [Abstract][Full Text] [Related]
26. The role of CB
Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744
[TBL] [Abstract][Full Text] [Related]
27. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.
Schlosburg JE; Kinsey SG; Ignatowska-Jankowska B; Ramesh D; Abdullah RA; Tao Q; Booker L; Long JZ; Selley DE; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2014 Aug; 350(2):196-204. PubMed ID: 24849924
[TBL] [Abstract][Full Text] [Related]
28. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
[TBL] [Abstract][Full Text] [Related]
29. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
Ignatowska-Jankowska B; Wilkerson JL; Mustafa M; Abdullah R; Niphakis M; Wiley JL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2015 May; 353(2):424-32. PubMed ID: 25762694
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
Sciolino NR; Zhou W; Hohmann AG
Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985
[TBL] [Abstract][Full Text] [Related]
31. Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice.
Ghosh S; Kinsey SG; Liu QS; Hruba L; McMahon LR; Grim TW; Merritt CR; Wise LE; Abdullah RA; Selley DE; Sim-Selley LJ; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2015 Aug; 354(2):111-20. PubMed ID: 25998048
[TBL] [Abstract][Full Text] [Related]
32. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048).
Aaltonen N; Kedzierska E; Orzelska-Górka J; Lehtonen M; Navia-Paldanius D; Jakupovic H; Savinainen JR; Nevalainen T; Laitinen JT; Parkkari T; Gynther M
J Pharmacol Exp Ther; 2016 Oct; 359(1):62-72. PubMed ID: 27451409
[TBL] [Abstract][Full Text] [Related]
33. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
[TBL] [Abstract][Full Text] [Related]
35. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.
Ignatowska-Jankowska BM; Ghosh S; Crowe MS; Kinsey SG; Niphakis MJ; Abdullah RA; Tao Q; O' Neal ST; Walentiny DM; Wiley JL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2014 Mar; 171(6):1392-407. PubMed ID: 23848221
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
Limebeer CL; Abdullah RA; Rock EM; Imhof E; Wang K; Lichtman AH; Parker LA
Psychopharmacology (Berl); 2014 Feb; 231(3):603-12. PubMed ID: 24043345
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
Muldoon PP; Akinola LS; Schlosburg JE; Lichtman AH; Sim-Selley LJ; Mahadevan A; Cravatt BF; Damaj MI
Neuropharmacology; 2020 Oct; 176():108170. PubMed ID: 32479813
[TBL] [Abstract][Full Text] [Related]
38. Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling.
Zhang X; Thayer SA
Neuropharmacology; 2018 Jan; 128():269-281. PubMed ID: 29061509
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury.
Piro JR; Suidan GL; Quan J; Pi Y; O'Neill SM; Ilardi M; Pozdnyakov N; Lanz TA; Xi H; Bell RD; Samad TA
J Neuroinflammation; 2018 May; 15(1):142. PubMed ID: 29759062
[TBL] [Abstract][Full Text] [Related]
40. Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2.
Martínez-Torres S; Cutando L; Pastor A; Kato A; Sakimura K; de la Torre R; Valjent E; Maldonado R; Kano M; Ozaita A
Brain Behav Immun; 2019 Oct; 81():399-409. PubMed ID: 31251974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]